From once-weekly to semi-weekly whole prostate gland stereotactic radiotherapy with focal boosting: Primary endpoint analysis of the multicenter phase II hypo-FLAME 2.0 trial
Lisa De Cock, Cédric Draulans, Floris J. Pos, Sofie Isebaert, Robin De Roover, Uulke A. van der Heide, Robert Jan Smeenk, Martina Kunze-Busch, Jochem van der Voort van Zyp, Hans de Boer, Linda G.W. Kerkmeijer, Karin Haustermans
Topics & Concepts
MedicineToxicityProstate cancerClinical endpointAcute toxicityProstateUrologyGenitourinary systemRadiation therapyInternal medicineOncologySurgeryGastroenterologyClinical trialCancerProstate Cancer Diagnosis and TreatmentAdvanced Radiotherapy TechniquesProstate Cancer Treatment and Research